Pennsylvania Hospital is built on a foundation of clear communication. It informs the way we discuss health goals and treatments with our patients, how we foster collaboration across departments, and how we share innovative breakthroughs with our local community and beyond. Last month, PAH was proud to host a press conference that highlighted the significant impact of empathetic and effective communication in the care of a well-known patient: former Governor Ed Rendell.
The Governor announced his Parkinson’s disease diagnosis that day, and in doing so, he hoped to inspire others struggling with symptoms to get the diagnosis and start treatment as early as possible. But while he rightly said, “Parkinson’s is not a death sentence,” he confessed that he hadn’t always been so sure and shared his fears of deterioration after watching his mother suffer from the disease.
His perception changed after he was referred to Matthew Stern, MD, director of Neurology and director emeritus of the Parkinson’s Disease and Movement Disorders Center, who insisted a full, active life was possible with the right combination of medication, exercise, and ancillary services. By debunking the popular misconceptions and ensuring Rendell made informed decisions about his healthcare journey, Dr. Stern was able to develop the best treatment plan for his rigorous lifestyle.
Regular communication between Rendell’s care teams at PAH and Good Shepherd Penn Partners has also been key. In addition to taking medication, he engages in therapy with Heather Cianci, PT, MS, GCS, at the Dan Aaron Parkinson’s Rehabilitation Center, and Cianci works with Rendell’s personal trainer to ensure everyone is on the same page. This multidisciplinary care has successfully helped him cope and halted the progression of his disease, and it demonstrates how critical these partnerships are in ensuring the best patient outcomes today — and in developing more efficient and effective care for the future.
With Dr. Stern’s encouragement, the Governor decided to make his public announcement after three years of treatment. Not only did his decision shed light on the reality of Parkinson’s disease, but it also reinforced the strides Penn has taken to lead the charge on Parkinson’s research, treatment, and rehabilitation. Making this announcement alongside Stern and Cianci and in the hospital where so many have contributed to his care is a testament to the dedication, compassion, and innovative spirit of our staff. I couldn’t be happier that he decided to take this courageous leap with us at Pennsylvania Hospital.